Skip to content

Treatment of psoriasis

A comparative clinical study of mustadi kwath and shashanklekhadi churna after virechana karma in ekakustha - ekakustha

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019192
Enrollment
40
Registered
2019-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Mustadi Kwath after Virechana karma: Virechana with Trivrit Avlehyam(A.H.K 2/9)Ingredient:1. Trivrit (Operculina turpethum Linn.), Twak (Cinnamomnm zeylanicum Breyn),Ela (Elettaria card

Sponsors

Campus Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical features of Ekakustha (Psoriasis). 2. Patients from age group of 15-60 years.

Exclusion criteria

Exclusion criteria: • Patient suffering from Asthma, HIV, Anemia, Tuberculosis. • Patient suffering from other major medical and psychiatric disorders. • Pregnant and lactating women. • Patients of age below 15 and more than 60 years.

Design outcomes

Primary

MeasureTime frame
This work is yet to be started and outcome will be assessed on the basis of subjective and objective parameters in 8 weeksTimepoint: This work is yet to be started and outcome will be assessed after every 4 weeks

Secondary

MeasureTime frame
The work is yet to be started and after primary outcome on an interval of 15 days secondary outcome will be assessedTimepoint: The work is due to be finished by May 2020

Countries

India

Contacts

Public ContactSangita Devi

Uttarakhand Ayurved University, Gurukul campus, Haridwar UTTRANCHAL

pandey.punita62@gmail.com9319394485

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026